文献速递神经重症与神经感染认知障碍与痴呆帕金森病与运动障碍

急性登革热感染相关的神经系统事件

Neurological Events Associated With Acute Dengue Infection.
PubMed 文献 · JAMA Neurol · 2026-01-01

该研究为新加坡回顾性人群队列研究,纳入2017至2023年65 207例确诊登革热成人及1 616 865例未感染对照,评估感染后急性期新发神经系统事件风险。登革热感染后30天任何新发神经系统事件、记忆丧失、运动障碍及其他神经系统事件的调整比值比均显著升高,但总体超额负担较低,每100例中不足1例超额事件。

要点

  • 登革热感染后30天新发神经系统事件风险显著升高(aOR 9.69)。
  • 记忆丧失和运动障碍风险升高,尤其在60岁及以上人群及登革热血清型3传播期感染者中。
  • 总体超额负担较低,每100例中不足1例超额事件。

核心结论

  • 登革热感染与感染后急性新发神经系统事件风险显著升高相关,但超额负担较低。
  • 老年人感染登革热后应监测更广泛的潜在神经系统并发症。

研究设计与样本

  • 回顾性人群队列研究,使用新加坡国家登记数据构建登革热感染组和未感染对照组。
  • 排除T0前30天内感染SARS-CoV-2者、T0前死亡者及无既往医疗接触的对照。
  • 采用重叠权重逻辑回归估计T0后30至90天新发神经系统事件的比值比。

主要发现

  • 登革热感染后30天,任何新发神经系统事件aOR为9.69(95% CI 6.59-14.90)。
  • 记忆丧失aOR为3.19(95% CI 1.36-8.69),运动障碍aOR为7.10(95% CI 2.49-29.18),其他神经系统事件aOR为14.32(95% CI 8.61-26.04)。
  • 风险轨迹在感染后90天内出现分离,但总体超额负担每100例中不足1例超额事件。
  • 仅在60岁及以上人群及登革热血清型3传播期感染者中,记忆丧失(aOR 2.99,95% CI 1.30-7.87)和运动障碍(aOR 6.38,95% CI 2.23-25.96)风险升高。

临床怎么用

  • 对急性登革热感染者,尤其60岁及以上人群,应警惕新发神经系统事件(如记忆丧失、运动障碍等)。
  • 登革热血清型3传播期感染者可能需更密切的神经系统监测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: With increasing global incidence of acute dengue virus (DENV) infection, more accurate estimates of the burden of neurological events following infection are required; however, population-based estimates are lacking. OBJECTIVE: To evaluate the risk and excess burden of neurological events in a cohort of DENV-infected adults in the acute postinfectious period vs population-based comparators without DENV infection. DESIGN, SETTING, AND PARTICIPANTS: This was a retrospective, population-based cohort study in Singapore. National registries were used to construct a cohort of all adults (aged ≥18 years) infected with DENV from January 1, 2017, through December 31, 2023, for whom the index date (time 0 [T0]) was taken as the date of notification, and a cohort of uninfected population-based comparators, for whom T0 was randomly assigned to match T0 distribution in DENV-infected cases. As the period overlapped with the COVID-19 pandemic, individuals infected with SARS-CoV-2 within 30 days of T0 were additionally excluded, as were individuals who died before T0 and uninfected comparators with no prior health care contact. Data analysis was performed from January 1, 2017, through March 30, 2024. EXPOSURE: DENV infection recorded in the national registry. MAIN OUTCOMES AND MEASURES: New-incident neurological events, including any neurological event, memory loss, movement disorders, and other neurological disorders (eg, fatigue or malaise, encephalitis or encephalopathy), following DENV infection were identified using national health care claims records, and risk was assessed over the acute follow-up period. Odds of new-incident neurological events in DENV-infected cases vs uninfected comparators were estimated using overlap-weighted logistic regression at 30 to 90 days after T0. RESULTS: A total of 65 207 confirmed DENV-infected cases (mean [SD] age, 48.4 [17.8] years; 34 876 [53.5%] male) were compared against 1 616 865 uninfected comparators (mean [SD] age, 54.8 [18.3] years; 730 702 [45.2%] male). At 30 days following DENV infection, individuals with DENV infection, compared with uninfected individuals, had elevated odds of any new-incident neurological event (adjusted odds ratio [aOR], 9.69; 95% CI, 6.59-14.90), memory loss (aOR, 3.19; 95% CI, 1.36-8.69), movement disorders (aOR, 7.10; 95% CI, 2.49-29.18), and other neurological events (aOR, 14.32; 95% CI, 8.61-26.04); risk trajectories diverged up to 90 days after infection. However, the overall excess burden was modest, with less than 1 excess event per 100 cases. The DENV-infected cases, compared with uninfected individuals, had increased odds of memory loss (aOR, 2.99; 95% CI, 1.30-7.87) and movement disorders (aOR, 6.38; 95% CI, 2.23-25.96) only among those aged 60 years or older and in cases infected during DENV serotype 3 transmission. CONCLUSIONS AND RELEVANCE: DENV infection was associated with significantly higher odds of acute new-incident neurological events following infection, although the excess burden was modest. Older adults should be monitored for a wider spectrum of potential neurological complications following DENV infection.

来源:JAMA Neurol,查看原文。版权归原作者所有。

引用

  1. Wee LE, Tan WZ, Chow JY, et al. Neurological Events Associated With Acute Dengue Infection. JAMA Neurol. 2026. PMID: 41284268. doi:10.1001/jamaneurol.2025.4608

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。